Intera Atlas
Run match
Sites / AMR Clinical
Is this you?

Request access for AMR Clinical with your @amr-clinical.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

AMR Clinical

Unclaimed profile

SMO / Site Network · Knoxville, TN; Research Triangle Park, NC · ~30+ sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.43Recruit soph 0.57
Quality Scorecard (1–100)
Overall76Recruit79Ops75Sponsor76Ther71

Performance (observed)

Historical trials
276
Completed
158
Terminated/Withdrawn
32
Completion rate
83%
Active now
84
Phase 2
91
Phase 3
144
Realized enrollment
554,855
First study year
2006
Years active
20
Match confidence
low
Enrollment velocity (inf)
27,743

Therapeutic

Areas
Multiple specialties; focused on endocrinology and obesity (575+ endocrinology studies, 100+ obesity studies)
Specialties
Multi-specialty Phase I-IV; obesity, COVID-19, renal, GI, metabolic disorders
Breadth (conditions)
214
Languages
English + Spanish (detected)
States
Multi-state (US continental)

Recruitment (web observed)

Trial Finder
Yes
Patient database
Y (1M+ participants)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong (site partnership, investigator content)
Capability notes
1M+ participants in database; 150,000+ enrolled; 8,000+ trials completed; fast startup, consistent enrollment goals, exceeds enrollment expectations

Relationships

Sponsors
Pfizer; Eli Lilly and Company; Sanofi Pasteur, a Sanofi Company; Boehringer Ingelheim; AbbVie; Janssen Vaccines & Prevention B.V.
CROs
IQVIA Pty Ltd; Parexel; Premier Research; The Emmes Company, LLC
Partnerships
None listed
Owner / parent
Recapitalized by Curewell Capital; founded 1994, consolidated 2017
Acquisitions
Acquiring clinical research sites
Expansion
Y (active partnership and acquisition opportunities)
Recent hiring
Y (investigator and site recruitment active)

Capacity & people

Investigators
—
Coordinators
—
CEO
Kari L. Delahunty (as of Dec 2025)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown

Tech & DCT

eSource
Yes
eConsent
Yes
Builds tech
Vendors (third-party systems; centralized oversight model)
Home visits
N
DCT / decentralized
Y (30+ sites across U.S.)
Tech stack
Centralized, integrated infrastructure; unnamed CTMS/data systems
Recruiting visible
Y

Notes

Large integrated multi-site network (30+ sites, 1M+ participants in database, 150,000+ enrolled). Specific strength in endocrinology and obesity (high-volume, recruitment-focused areas). Excellent enrollment track record. CEO succession (Delahunty from COO) shows operational maturity. Limited tech innovation (no AI mentioned) but strong recruitment capability and high-volume trial focus. Excellent Intera fit given scale, endocrinology/obesity focus (recruitment-heavy), and enrollment track record. [Validated: 9 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.43Overall76

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.